Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHRP-6

Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

Quick Stats
Studies 702
Trials 0
Score 2
1998 pubmed

Effects of growth hormone secretagogues on prolactin release in anesthetized dwarf (dw/dw) rats.

Carmignac. D F DF; Bennett. P A PA; Robinson. I C IC

Key Findings

  • GHRP‑6 stimulates GH release in all rats but only triggers prolactin release in GH‑deficient dwarf (dw/dw) females.
  • Estrogen (E2) is required for the prolactin response: ovariectomy removes it, and giving E2 restores it even in males.
  • The prolactin effect is independent of TRH signaling and likely due to increased GH secretagogue receptor expression in the brain.

Practical Outcomes

  • For most users, GHRP‑6 is unlikely to cause a prolactin surge, so concerns about prolactin‑related side effects are minimal. However, individuals with low GH or high estrogen levels might see a modest prolactin increase, so monitoring may be wise if those conditions apply.

Summary

In normal male and female rats, the peptide GHRP‑6 does not raise prolactin levels, but in growth‑hormone‑deficient dwarf rats it can increase prolactin, especially when estrogen is present. This effect seems to come from direct action on the pituitary and is separate from its growth‑hormone‑boosting action.

Abstract

In addition to stimulating GH release, GH secretagogues such as GH-releasing peptide-6 (GHRP-6) stimulate small amounts of ACTH and PRL release. Although the effects on ACTH have recently been studied, there is little information about the effects of GHRP-6 on PRL. We have now studied GHRP-6-induced GH and PRL release and their regulation by estrogen (E2) in anesthetized male and female rats and in GH-deficient dwarf (dw/dw) rats that maintain high pituitary PRL stores and show elevated hypothalamic GH secretagogue receptor expression. Whereas GHRP-6 (0.1-2.5 microg, i.v.) did not induce PRL release in normal male or female rats, significant PRL responses were observed in dw/dw females. These responses were abolished by ovariectomy and could be strongly induced in male dw/dw rats by E2 treatment. These effects could be dissociated from GHRP-6-induced GH release in the same animals, but not from PRL release induced by TRH, which was also abolished by ovariectomy and induced in males by E2 treatment. However, the effects of GHRP-6 on PRL were unlikely to be mediated by TRH because in the same animals, TSH levels were unaffected by GHRP-6 whereas they were increased by TRH. The increased PRL response could reflect an increase in GH secretagogue receptor expression that was observed in the arcuate and ventromedial nuclei of E2-treated rats. Our results suggest that the minimal PRL-releasing activity of GHRP-6 in normal rats becomes prominent in GH-deficient female dw/dw rats and is probably exerted directly at the pituitary; these GHRP-6 actions may be modulated by E2 at both hypothalamic and pituitary sites.

Study Information

Provider

pubmed

Year

1998

DOI

10.1210/endo.139.8.6148